Acadian Asset Management
CLPT icon

Acadian Asset Management’s ClearPoint Neuro CLPT Stock Holding History

Acadian Asset Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,768
Closed -$42K – 1710
2024
Q3 		$42K Buy
+3,768
New +$36.1K ﹤0.01% 1840

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acadian Asset Management's CLPT Position: Q4 2024 in Review

Acadian Asset Management sold out of ClearPoint Neuro (CLPT) in Q4 2024, closing a stake of 3,768 shares — an estimated $42K sold.

Acadian Asset Management first reported a position in CLPT in Q3 2024 and held it in 1 quarter. The position peaked at $42K in Q3 2024. 89 funds tracked by Wall St. Rank hold CLPT as of Q4 2024.

  • Acadian Asset Management reported no remaining ClearPoint Neuro position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 3,768 ClearPoint Neuro shares in Q4 2024, an estimated $42K.
  • Acadian Asset Management first reported a position in ClearPoint Neuro in Q3 2024 and held it in 1 quarter.
  • Acadian Asset Management's ClearPoint Neuro position peaked at $42K in Q3 2024.
  • 89 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.